Pfizer Settles Retail Pharmacies' Antitrust Claims

Law360, New York (November 12, 2013, 5:42 PM EST) -- Pfizer Inc. has reached a settlement with thousands of independent pharmacies to exit litigation alleging it colluded with other drugmakers to charge the retailers higher prices than other preferred customers, leaving them at an unfair disadvantage, according to a motion filed in New York federal court Friday.

Pfizer and two subsidiaries, G.D. Searle & Co. and Pharmacia & Upjohn Co., struck the deal with more than 4,000 independent pharmacies across the country, the motion to dismiss their price-discrimination claims indicated.

In a series of lawsuits consolidated...
To view the full article, register now.